BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14565238)

  • 41. Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase.
    Sweeney ZK; Acharya S; Briggs A; Dunn JP; Elworthy TR; Fretland J; Giannetti AM; Heilek G; Li Y; Kaiser AC; Martin M; Saito YD; Smith M; Suh JM; Swallow S; Wu J; Hang JQ; Zhou AS; Klumpp K
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4348-51. PubMed ID: 18625554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
    Su DS; Lim JJ; Tinney E; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Prasad S; Yan Y; Perlow-Poehnelt R; Torrent M; Miller M; Vacca JP; Williams TM; Anthony NJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5119-23. PubMed ID: 19631528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages.
    Aquaro S; Svicher V; Ceccherini-Silberstein F; Cenci A; Marcuccilli F; Giannella S; Marcon L; Caliò R; Balzarini J; Perno CF
    J Antimicrob Chemother; 2005 Jun; 55(6):872-8. PubMed ID: 15845785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Wang YP; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Bioorg Med Chem; 2008 Apr; 16(7):3887-94. PubMed ID: 18267363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
    Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
    J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and anti-HIV activity of beta-D-3'-azido-2',3'-unsaturated nucleosides and beta-D-3'-azido-3'-deoxyribofuranosylnucleosides.
    Gadthula S; Chu CK; Schinazi RF
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1707-27. PubMed ID: 16438043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and anti-HIV activities of glutamate and peptide conjugates of nucleoside reverse transcriptase inhibitors.
    Agarwal HK; Chhikara BS; Quiterio M; Doncel GF; Parang K
    J Med Chem; 2012 Mar; 55(6):2672-87. PubMed ID: 22352809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazines.
    Xiong YZ; Hu HR; Chen FE; Balzarini J; Pannecouque C; de Clercq E
    Yao Xue Xue Bao; 2009 Feb; 44(2):145-9. PubMed ID: 19408683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities.
    Scaglione F; Berrino L
    Int J Antimicrob Agents; 2012 Jun; 39(6):458-63. PubMed ID: 22269860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents.
    Lee K; Chu CK
    Antimicrob Agents Chemother; 2001 Jan; 45(1):138-44. PubMed ID: 11120956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microwave-assisted synthesis and anti-HIV activity of new acyclic C-nucleosides of 3-(D-ribo-tetritol-1-yl)-5-mercapto-1,2,4-triazoles. Part 1.
    Al-Soud YA; Al-Masoudi NA; Schuppler T; De Clercq E; Pannecouque C
    Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):469-83. PubMed ID: 18569786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, biological properties and anti-HIV-1 activity of new pyrimidine P1,P2-dinucleotides.
    Miazga A; Ziemkowski P; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):438-44. PubMed ID: 20544533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV.
    Yang H; Qi X; Sabogal A; Miller M; Xiong S; Delaney WE
    Antivir Ther; 2005; 10(5):625-33. PubMed ID: 16152756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
    Xu B; Sun Y; Guo Y; Cao Y; Yu T
    Bioorg Med Chem; 2009 Apr; 17(7):2767-74. PubMed ID: 19269831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thiated analogues of 2',3'-dideoxy-3'-fluorothymidine and their phosphorylated and phosphonylated derivatives: synthesis, interaction with HIV reverse transcriptase, and in vitro anti-HIV activity.
    Miazga A; Felczak K; Bretner M; Siwecka MA; Piasek A; Kulikowski T
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):973-5. PubMed ID: 14565324
    [No Abstract]   [Full Text] [Related]  

  • 57. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
    Wang RR; Yang QH; Luo RH; Peng YM; Dai SX; Zhang XJ; Chen H; Cui XQ; Liu YJ; Huang JF; Chang JB; Zheng YT
    PLoS One; 2014; 9(8):e105617. PubMed ID: 25144636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants.
    Cancio R; Mai A; Rotili D; Artico M; Sbardella G; Clotet-Codina I; Esté JA; Crespan E; Zanoli S; Hübscher U; Spadari S; Maga G
    ChemMedChem; 2007 Apr; 2(4):445-8. PubMed ID: 17323401
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis and anti-HIV activity of novel phenyl branched cyclopropyl nucleosides.
    Wu Y; Hong JH
    Farmaco; 2005 Sep; 60(9):739-44. PubMed ID: 16038909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.